This inventor holds 6 USPTO granted patents and 5 EPO patents. Top assignee: Caregen Co., Ltd. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovative Contributions of Eun Mi Kim
Introduction
Eun Mi Kim is a prominent inventor based in Anyang-si, Gyeonggi-do, South Korea. She has made significant contributions to the field of biotechnology, particularly in the development of peptides with therapeutic applications. With a total of 6 patents to her name, Eun Mi Kim is recognized for her innovative work and dedication to advancing medical science.
Latest Patents
Among her latest patents is the "TROLOX-PEPTIDE CONJUGATE AND USE THEREOF," which showcases her expertise in creating novel compounds. Additionally, she has developed a "PEPTIDE WITH NEUTRALIZING ACTIVITY AGAINST SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2," highlighting her commitment to addressing critical health challenges.
Career Highlights
Eun Mi Kim is currently employed at Caregen Co., Ltd., a company known for its focus on regenerative medicine and biotechnology. Her role at Caregen has allowed her to collaborate with other talented professionals in the field, further enhancing her contributions to innovative research.
Collaborations
Eun Mi Kim has worked alongside notable colleagues, including Eung Ji Lee and Yong Ji Chung. These collaborations have fostered a dynamic environment for innovation and have led to the development of groundbreaking solutions in biotechnology.
Conclusion
Eun Mi Kim's work exemplifies the spirit of innovation in the field of biotechnology. Her patents and collaborations reflect her commitment to advancing medical science and improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile